These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 8627247

  • 1. Proliferative T cell responses to human papillomavirus type 16 L1 peptides in patients with cervical dysplasia.
    Shepherd PS, Rowe AJ, Cridland JC, Coletart T, Wilson P, Luxton JC.
    J Gen Virol; 1996 Apr; 77 ( Pt 4)():593-602. PubMed ID: 8627247
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. T cell proliferative responses against human papillomavirus type 16 E7 oncoprotein are most prominent in cervical intraepithelial neoplasia patients with a persistent viral infection.
    de Gruijl TD, Bontkes HJ, Stukart MJ, Walboomers JM, Remmink AJ, Verheijen RH, Helmerhorst TJ, Meijer CJ, Scheper RJ.
    J Gen Virol; 1996 Sep; 77 ( Pt 9)():2183-91. PubMed ID: 8811018
    [Abstract] [Full Text] [Related]

  • 6. Detection of antibodies to a linear epitope on the major coat protein (L1) of human papillomavirus type-16 (HPV-16) in sera from patients with cervical intraepithelial neoplasia and children.
    Cason J, Kambo PK, Best JM, McCance DJ.
    Int J Cancer; 1992 Feb 01; 50(3):349-55. PubMed ID: 1310487
    [Abstract] [Full Text] [Related]

  • 7. Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: outcome of HPV infection and associated neoplasia.
    Kadish AS, Ho GY, Burk RD, Wang Y, Romney SL, Ledwidge R, Angeletti RH.
    J Natl Cancer Inst; 1997 Sep 03; 89(17):1285-93. PubMed ID: 9293919
    [Abstract] [Full Text] [Related]

  • 8. Serological and T-helper cell responses to human papillomavirus type 16 L1 in women with cervical dysplasia or cervical carcinoma and in healthy controls.
    Luxton JC, Rose RC, Coletart T, Wilson P, Shepherd PS.
    J Gen Virol; 1997 Apr 03; 78 ( Pt 4)():917-23. PubMed ID: 9129666
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Increased expression of programmed death (PD)-1 and its ligand PD-L1 correlates with impaired cell-mediated immunity in high-risk human papillomavirus-related cervical intraepithelial neoplasia.
    Yang W, Song Y, Lu YL, Sun JZ, Wang HW.
    Immunology; 2013 Aug 03; 139(4):513-22. PubMed ID: 23521696
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. T-cell response to human papillomavirus type 58 L1, E6, And E7 peptides in women with cleared infection, cervical intraepithelial neoplasia, or invasive cancer.
    Chan PK, Liu SJ, Cheung TH, Yeo W, Ngai SM, Cheung JL, Chong P, Man S.
    Clin Vaccine Immunol; 2010 Sep 03; 17(9):1315-21. PubMed ID: 20668141
    [Abstract] [Full Text] [Related]

  • 16. IgG antibodies to HPV16, 52, 58 and 6 L1-capsids and spontaneous regression of cervical intraepithelial neoplasia.
    Matsumoto K, Yasugi T, Oki A, Fujii T, Nagata C, Sekiya S, Hoshiai H, Taketani Y, Kanda T, Kawana T, Yoshikawa H.
    Cancer Lett; 2006 Jan 18; 231(2):309-13. PubMed ID: 16399232
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Proliferative T-cell responses to human papillomavirus type 16 E5 are decreased amongst women with high-grade neoplasia.
    Gill DK, Bible JM, Biswas C, Kell B, Best JM, Punchard NA, Cason J.
    J Gen Virol; 1998 Aug 18; 79 ( Pt 8)():1971-6. PubMed ID: 9714245
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. T-cell response to human papillomavirus type 52 L1, E6, and E7 peptides in women with transient infection, cervical intraepithelial neoplasia, and invasive cancer.
    Chan PK, Liu SJ, Cheung JL, Cheung TH, Yeo W, Chong P, Man S.
    J Med Virol; 2011 Jun 18; 83(6):1023-30. PubMed ID: 21503915
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.